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to survive longer than other enteroviruses and are a good
indication of the quality of the water.
Although viruses were detected in samples taken from various
points during reclamation before the final chlorination stage, it
would appear that the fmal water from the reclamation plant is
completely free of viral contamination and is as clear as
domestic tap-water. The fact that there was a heavier deposit
of discoloured matter on the membrane filter after tap-water
had been concentrated would be because of its storage and
passage through many pipes.
By virological standards the final water from the Cape Flats
reclamation plant is perfectly potable.
The results presented here confirm those reported by the
National Institute for Water Research of the South African
Council for Scientific and Industrial Research4 on its studies
of a similar pilot plant in Pretoria (Stander Plant) and those
reported by Isaacson er al. 5 for the Windhoek reclamation
plant.
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Blastomyces dermatitidis infections in the RSA
J. A. FREAN, W. F. CARMAN, H. H. CREWE-BROWN, G. A. CULLlGAN, C. N. YOUNG
Summary
Twenty cases of blastomycosis have been confirmed in the
RSA, 9 of which are presented for the first time. Patients
came from all four provinces and the mean age was 40 years.
Six cases were diagnosed between 1985 and 1987. Differ-
ences between strains of Blastomyces dermatitidis isolated in
the RSA and in North America include morphological and
cultural characteristics, mycelial-yeast conversion, antigenic
structure, and .compatibility in cross-mating experiments. The
diagnosis of this disease can be made by direct examination
of unstained specimens, by histological examination or by
culture of the organism. Culture should· be aUempted in all
cases for confirmation of microscopic findings.
S AIr Med J 1989; 76: 13-16.
Blastomycosis was first described in North America, where
most cases have occurred. The disease is a systemic infection
caused by the dimorphic fungus Blasramyces dennariridis. The
clinical presentation of patients in North America and Africa
is similar; only minor differences appear.
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The portal of entry of the infectious conidia is the lung,
from where dissemination occurs, mainly to skin and bone.
The kidney and prostate are other organs commonly involved.
In the lung, the disease process may be acute or chronic, the
latter presenting in a similar fashion to tuberculosis or
carcinoma. Involvement of almost every tissue has been
documented.
A number of reports of blastomycosis have appeared in the
SAMJ recentiy.l-3 We contacted microbiologists and clinicians
in major centres in South Africa (Joharmesburg, Pretoria,
Bloemfontein, Cape Town and Durban) and obtained details
of 9 unpublished cases, which have occurred over the last 10
years, bringing to 20 the total number of blastomycosis cases
reported in this country since 1959.4
A survey of published reports showed that 57 cases have
been described in African countries other than South Africa
since the first report in 1952.5 Of these, 28 occurred in
Zimbabwe,6-1O 5 in Zaire,Il-13 4 in Morocco,14-17 3 in Tunisia/,ls,18
3 in Zambia,12,19 2 each in Mozambique/o-21 Nigeria12,22 and
Libya,12,23 and I each in Algeria,24 Egypt,12 the Gambia,25
Liberia,26 Malawi,12 Rwanda,2' Tanzania28 and Uganda.28 In
addition, we know of I Mozambican, I South West African!
Namibian and 2 Zimbabwean cases that have not been
published. Thus, to date, the total number of cases reported
from Africa is 81.
Examples of South African cases which illustrate the clinical
features and treatment of the infection can be found in recent
publications,I-3 but little has been written about the causative
organism. Therefore what is known of the epidemiology of the
disease in the RSA, the comparative mycology of the fungal
strains responsible for the disease in Africa and North America,
and information to help both those submitting and those
processing specimens to make the diagnosis of blastomycosis is
presented.
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TABLE I. SOUTH AFRICAN CASES OF BLASTOMYCOSIS
Year of Age
Province diagnosis (yrs) Sex Race Reference
Cape Province 1985 40 M B Unpublished
Orange Free State 1961 29 M B Emmons et al.28
1983 34 M B Unpublished
1975 A M B Unpublished
1985 29 M B Berkowitz and Diamond3
Natal 1968 36 M W Martin and Berson4
1970 39 M B Osmond et al.38
1973 17 F ? Unpublished
1978 65 M ? Unpublished
1986 44 M B Allanson and McCallum35
Transvaal 1959 50 F B Martin and Berson4
1967 27 M B Martin and Berson4
1975 46 M B Fragoyannis et al. 3•
1975 63 M W Simon et a/.40
1975 ? M B Unpublished
1984 37 M B Unpublished
1985 45 M B De Villiers et al.2
1985 47 M W Hurwitz et al.'
1987 26 M B Unpublished
We are aware of 1 more unpublished case involving a black male which was diagnosed during 1975 - 1985 but no other
details are available.
A = adul~ F = female; M = male; B = black; W = white.
I
~ Date of diagnosis
o Date of publication if dale of
diagnosis is not known.
population as a whole. This might be explained either by the
fact that black people do not present to hospital as often as
whites or by misdiagnosis.
Comparative mycology















A number of authors have addressed the problem of whether
the North American and African isolates of B. dermariridis
represent different species or merely different serotypes.
Morphological differences have been described: cultures of
North American isolates tended to be velvety white becoming
tan in colour, with yeast cells 8 - 12 pm in diameter. In
contrast, African isolates were moist and glabrous' with a
furrowed mycelium, and yeast cells were 9 - 18 pm in dia-
meter. 31 A tendency of the yeast forms of some African isolates
to fllamentation or hyphal element production, resulting in
bizarre swollen cells, has been noted31 and was also seen by
one of the authors (c. N. Y. - unpublished observation).
Fig. 1. Published and unpublished cases of blastomycosis in
South Africa by year of diagnosis or of publication.
Epidemiology
Table I shows some epidemiological data concerning South
African cases of blastomycosis. Cases have been diagnosed in
all provinces, with the Transvaal the best represented; this
province is also the most populous. However, in other regions
of the world the incidence is more closely related to exposure
to environmental conditions favouring sporulation of the
fungus29 than to the population size. It may be that from time
to time suitable conditions exist in the Transvaal more often
than in the other provinces. These conditions are usually
found in circumscribed sites; an example is the recently
described outbreak associated with a beaver lodge in
Wisconsin.3o A localised outbreak such as this has not been
described in South Africa; however, 2 patients, widely separated
in time, are known to have come from Welkom in the Orange
Free State (OFS). Similarly, 2 cases of blastomycosis occurred
in patients living in the Maflkeng area of the western Transvaal.
There seems to be an inverse relationship between latitude and
incidence; only 1 case has been diagnosed in the Cape Province,
4 in Natal, 5 in the OFS, 9 in the Transvaal, and more than 25
cases have been described from Zimbabwe.6- 1O The organism
has not been recovered from the environment in southern
Africa, and even in North America this has been accomplished
only a few times.30
Fig. 1 shows the distribution of the cases over time. It is
possible that the conditions of temperature and humidity
necessary for sporulation of the organism were more often
present during some periods than during others, leading to
peaks in incidence such as occurred during the years 1985
-1987.
The age of the patients ranges from 17 years to 65 years,
with a mean of 40 years. Only 2 patients have been women,
which may be a reflection of a greater exposure to the fungus
in outdoor occupations of men. Since outdoor exposure is
considered to be a risk factor, it could be expected that blacks
would have a much greater incidence than whites, especially in
agricultural areas. However, the ratio of black to white patients
is only 4: 1 in this series, i.e. lower than the ratio in the
Vermeil et aP2 pointed out that the ability of the mycelial
phase to conven to the yeast phase was abolished or lessened
in the African strains, in contrast with the American ones,
which routinely achieve this conversion. Kaufman et al. 31
succeeded in getting 7 of 11 African strains to conven fully.
Serological differences have been noted consistently; studies
in which immunoprecipitation31 and immunofluorescence33
were used, showed that American isolates were antigenically
more complex. Kaufman et aPl found antigens which they
designated A and K. The K antigen was common to all
strains, regardless of geographic origin, whereas the A antigen
was found in American, but not in African strains, apan from
a solitary Algerian isolate. Single isolates from India and Israel
also had the A antigen.
Cross-mating experiments, in which African and Nonh
American strains were paired, showed that true sexual spore
formation did not occur,34 implying that the paired strains
were not identical species.
These studies have been done on relatively small numbers
of strains and more isolates need investigation to confirm these
differences.
Diagnosis
The diagnosis of blastomycosis should be considered in patients
who present with chronic subcutaneous abscesses or verrucous
crusting skin lesions; who have bone abscesses tracking to the
skin surface, panicularly when the spine or ribs are involved;
or who have chronic pulmonary disease not responding to
antituberculosis therapy.
The preferred specimens are pus, skin biopsies or scrapings,
sputum and urine; fluid or biopsy material from any suspected
site would, however, be appropriate. Biopsy material should
be submitted both in formalin for histological examination and
in normal saline for culture.
Since B. dermatitidis is a dimorphic fungus, the yeast forms
are found in tissue. They are 7 - 20 ).Lm in diameter, thick-
walled, with characteristic single broad-based buds. Micro-
abscesses or non-caseating granulomas are usually found. The
organisms may be found free in the abscesses or inside giant
cells. HaematolCylin and eosin staining will be adequate in
most cases to make a diagnosis; however, special stains such as
methenamine silver and periodic acid-Schiff (PAS) should be
used for confirmation (Figs 2 and 3). Even with the methena-
mine silver stain it may be difficult to distinguish between
small forms of B. dermatitidis and Hiscoplasma capsulacum. The
Fig. 2. Section of sinus tract biopsy specimen (H and E x 1 000
-original magnification).
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Fig. 3. Section of sinus tract biopsy specimen (methenamine-
silver x 1 000 - original magnification).
PAS stain shows the multiple nuclei of B. dermacitidis, thus
differentiating it from all other similar organisms which are
uninucleate.
Potassium hydroxide (KOH) preparations may reveal the
presence of the yeasts in pus and body fluids (Fig. 4).
Papanicolaou staining of alcohol-fixed smears may demonstrate
the organism. 35 These rapid methods enable therapy to be
started immediately, but irrespective of the results, culture







Fig. 4. Potassium hydroxide preparation of pus (original magnifi-
cation = x 400).
The organism is readily cultured from fluids or biopsy
material on standard mycological media, such as Sabouraud's
agar. Plates must be incubated at room temperature and at
37°C to demonstrate both mycelial and yeast phases respec-
tively; the yeast phase requires enriched media such as blood
agar to grow. Although growth may be detected within 10
days, plates should be kept for 8 weeks before being regarded
as negative. In culture, the yeast forms are identical to those
seen in specimens. The mycelium is white and fluffy, although
it may become tan as the colony matures. Microscopically,
thin septate branching hyphae are seen. Ovoid conidia (2 - 10
).Lm in size) are either sessile or borne on short lateral conidio-
phores.
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Identification of the yeast phase can be confirmed by
immunological means, e.g. immunofluorescence. Immuno-
fluorescence can also be used to show the organism in tissue
sections.36
Although not available in the RSA, serology has a role in
diagnosis. A number of techniques, such as complement fIxation
and immunodiffusion, have been used for many years in the
USA but these, although specifIc (100% for both), are not very
sensitive (40% and 65% respectively, in one smdy)Y Recently,
an enzyme-linked immunosorbent assay (ELISA), using puri-
fIed yeast A antigen for the solid phase, has been described.37
This test, although marginally less specifIc (98%), had a sensi-
tivity of 80% for human blastomycosis. The ELISA might be
more suitable for serosurveys than the complement fIxation or
immunodiffusion tests. In the African context, we doubt
whether this ELISA would be of value because Of the absence
of the appropriate antigen (see above) in African strains. A
more useful ELISA for this region would require antigenic
analysis of local strains.
In vitro lymphocyte transformation using an alkali- and
water-soluble extract of the yeast phase has been used for the
diagnosis of blastomycosis in an outbreak in the USA.30 The
sensitivity of this test was 81 % (specifIcity was not reponed)
and it may (with the ELISA) provide the only evidence of
subclinical infection.
Skin testing with blastomycin, an extract of the mycelial
phase of the fungus, is neither specifIc nor sensitive.
Conclusion
Although it is a rare disease in the RSA, blastomycosis should
be entenained as a possible diagnosis when the clinician is
faced with a patient suffering from chronic skin, lung or bone
disease. The infection is relatively easily diagnosed if the
correct specimens are submitted and laboratory personnel.are
aware of the condition.
Fonunately, blastomycosis is eminently treatable.
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